Provention Bio Inc - ESG Rating & Company Profile powered by AI
The ESG assessment for Provention Bio Inc represents the company's reporting of the United Nations Sustainable Development Goals. The analysis of Provention Bio Inc uses information from across the web and also from available disclosures by Provention Bio Inc. Scroll down to the end of the webpage for potential risks for Provention Bio Inc based on industry, geography and size.
Provention Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 6.0, social score of 6.4 and governance score of 8.0.
6.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 294 | SMS Pharmaceuticals Ltd | 6.9 | High |
| 294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
| 314 | Provention Bio Inc | 6.8 | High |
| 314 | Camurus AB | 6.8 | High |
| 314 | Cassiopea SpA | 6.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Provention Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Provention Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Provention Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes Provention Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Provention Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Provention Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Provention Bio Inc offer flexible work?
Sign up for free to unlockDoes Provention Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Provention Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Provention Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes Provention Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Provention Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Provention Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Provention Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Provention Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Provention Bio Inc disclose water use targets?
Sign up for free to unlockDoes Provention Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Provention Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Provention Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Provention Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Provention Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Provention Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Provention Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Provention Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Provention Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Provention Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Provention Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Provention Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Provention Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Provention Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Provention Bio Inc disclose its waste policy?
Sign up for free to unlockDoes Provention Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Provention Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Provention Bio Inc disclose energy use targets?
Sign up for free to unlockDoes Provention Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Provention Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Provention Bio Inc
These potential risks are based on the size, segment and geographies of the company.
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.